Based on slides 36-38, I am confused why the market is not currently reacting possitively. Is this merely a PR issue (no one knows about these unbelievable numbers)? Is the market nervous about the business (fund)amentals?
It would appear this was a gold mine based on 208's relationship with these two drugs alone, not even considering what looks like an overal possitive set of data in most other categories...
Anyone care to speculate?